Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Efficacy and safety of MR-guided adaptive simultaneous integrated boost radiotherapy to primary lesions and positive lymph nodes in the neoadjuvant treatment of locally advanced rectal cancer: a randomized controlled phase III trial

Fig. 1

Workflow. LARC: locally advanced rectal cancer; LCCRT: long course concurrent radiotherapy and chemotherapy; MRgART-SIB: MRI-guided simultaneous integrated boost radiotherapy; CAPOX: capecitabine and oxaliplatin; FOLFOX: 5-fluorouracil, leucovorin and oxaliplatin; TME: total mesorectal excision

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us